V4B-11022-91894
2 vaccinations
2 coded responses
5 check-ins
2 free-text entries
2 call cases
- Sex
- Female
- Age at first dose
- 41-45
- ZIP prefix
- 062 / CT
- Registered
- 2021-05-11
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-04-20
Dose 1 — Pfizer-BioNTech
-
2021-05-11
Registered in v-safe
-
2021-05-11
Dose 2 — Pfizer-BioNTech
-
2021-05-11
Health check-in — 0 day, dose 2Feeling: Fair · Headache, Fatigue or tiredness, NauseaAdult check-in
- 2021-05-13
- 2021-05-14
-
2021-08-10
Survey response — 3 month, dose 2MedDRA: Acute cardiac event, Hospitalisation, Multiple sclerosis, Pre-existing disease — Feeling: Fair · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultation, Outpatient clinic or urgent care clinic visit, Emergency room or emergency department visit, HospitalizationMedDRA releases: 2021-09,2024-11 · check-in answers available
-
2021-08-10
Report sent to call center — 3 month, dose 2Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare pr1 call case(s)
- 2021-08-18
-
2021-11-12
Survey response — 6 month, dose 2MedDRA: Heart rate decreased, Hospitalisation, Peripheral swelling, Syncope, Ventricular tachycardia — Feeling: Fair · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Emergency room or emergency department visit, HospitalizationMedDRA releases: 2024-11 · check-in answers available
-
2021-11-12
Report sent to call center — 6 month, dose 2Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare prEmergency room or emergency department visit · Hospitalization · 1 call case(s)
- 2021-11-15
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-04-20 | Pfizer-BioNTech | |
| 2 | 2021-05-11 | Pfizer-BioNTech |
Call center
| Reported | Outcome | VAERS-related outcome |
|---|---|---|
| 2021-08-10 | Unsuccessful | |
| 2021-11-12 | Unsuccessful |
Free text
Release 9
Symptoms: MS exacerbation and cardiac episode. Hospital stay for 5 days.
Release 10
Symptoms: Swollen left leg and arm. Not bilateral. Hospitalized at the end of July for fainting with low heart rate. Episode of no heartbeat for 16 seconds in the hospital.
Free-text releases are not linked to a specific survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Acute cardiac event | ✓ | · | ✓ |
| SD | Heart rate decreased | · | · | ✓ |
| SD | Hospitalisation | ✓ | · | ✓ |
| SD | Multiple sclerosis | ✓ | · | ✓ |
| SD | Peripheral swelling | · | · | ✓ |
| SD | Pre-existing disease | ✓ | · | ✓ |
| SD | Syncope | · | · | ✓ |
| SD | Ventricular tachycardia | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release